Michael Catelani - 03 Jan 2023 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIX	Employee Stock Option (Right to Buy)	Award	$0	+350,000		$0	350,000	03 Jan 2023	Common Stock	350,000	$4.19	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2	The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2023.